Researchers at Monash University, together with a multidisciplinary team of healthcare professionals and medication safety experts, have developed the first national consensus list of medicines with a high risk of harm in Australian residential aged care.
Published in the Australasian Journal on Ageing, the study identified 15 high-risk medications or medication classes that require specialised monitoring in aged care settings.
These medications carry a significant risk of serious harm or death if misused or used in error.
Health professionals and health service organisations are required to have systems in place to identify and mitigate the risks associated with high-risk medications specific to their setting, but existing high-risk medication lists are not tailored to the unique and complex needs of aged care.
Dr Amanda Cross, lead author and a senior research fellow from the Centre for Medicine Use and Safety at the Monash Institute of Pharmaceutical Sciences, said the “OZ-ABCD” mnemonic she developed fills a “critical void” in Australia’s aged care safety resources.
“We need a high-risk medication list that is tailored to the needs of Australian residential aged care,” Dr Cross said.
“The OZ-ABCD tool gives busy clinicians and aged care staff a simple, memorable way to identify high-risk medications and ensure systems and monitoring are in place to keep residents safe.”
The OZ-ABCD mnemonic, standing for Opioids, Z-drugs and benzodiazepines, Antipsychotics and lithium, Blood thinners, Chemotherapeutic agents and methotrexate, and Diabetes agents with high risk of hypoglycaemia, offers a clear, practical tool to support education and improve practice.
The list was developed through a rigorous national consensus process involving a multidisciplinary group of healthcare professionals and medication safety experts.
Researchers said the tool will support better education and clinical practice, ultimately reducing the incidence of preventable medication-related injuries among vulnerable older Australians.
A component of this research was funded by a Medical Research Future Fund (MRFF) Primary Care Data Infrastructure Grant (PHRDI000008) led by Professor Nadine Andrew.
Read the research paper: doi.org/10.1111
RESEARCHERS
Researchers from the Centre for Medicine Use and Safety within the Monash Institute of Pharmaceutical Sciences also included Madiha Chaudhry, Darshna Goordeen, Louise Lord, Brigid McInerney, Justin Turner and Simon Bell. They were joined by a multidisciplinary team of health professionals from across Monash University, the University of Sydney, the University of Western Australia, the University of Melbourne, the Australian National University, the Wicking Dementia Research and Education Centre at the University of Tasmania, Ambulance Victoria, the Royal Australian College of General Practitioners, the South Australian Ambulance Service, and other universities and health services across Australia.
MEDIA ENQUIRIES
Philip Ritchie
Media and Communications Manager
P: +61 430 336 243
GENERAL MEDIA ENQUIRIES
Monash Media
P: +61 3 9903 4840
For more experts, news, opinion and analysis, visit Monash News.